The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Prospects for new restorative and neuroprotective treatments in Parkinson's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., & Seitelberger, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,651
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
FGF and Shh Signals Control Dopaminergic and Serotonergic Cell Fate in the Anterior Neural Plate
Ye, W., Shimamura, K., Rubenstein, J. L. R., Hynes, M. A., & Rosenthal, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81437-3 · Cited by 879
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL
Scoppetta, C., & Vaccario, M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 753
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy
Choi-Lundberg, D. L., Lin, Q., Chang, Y.-N., Chiang, Y. L., Hay, C. M., Mohajeri, H., Davidson, B. L., & Bohn, M. C. (1997) · Science · doi:10.1126/science.275.5301.838 · Cited by 625
SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASE
Marsden, C. D., & Parkes, J. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91146-1 · Cited by 587
Rate of cell death in parkinsonism indicates active neuropathological process
McGeer, P. L., Itagaki, S., Akiyama, H., & McGeer, E. G. (1988) · Annals of Neurology · doi:10.1002/ana.410240415 · Cited by 556
Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats
Studer, L., Tabar, V., & McKay, R. (1998) · Nature Neuroscience · doi:10.1038/1105 · Cited by 529
AETIOLOGY OF PARKINSON'S DISEASE
Calne, D., & William Langston, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90802-4 · Cited by 469
Deacon, T., Schumacher, J., Dinsmore, J., Thomas, C., Palmer, P., Kott, S., Edge, A., Penney, D., Kassissieh, S., Dempsey, P., et al. (1997) · Nature Medicine · doi:10.1038/nm0397-350 · Cited by 463
A susceptibility locus for Parkinson's disease maps to chromosome 2p13
Gasser, T., Müller-Myhsok, B., Wszolek, Z. K., Oehlmann, R., Calne, D. B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P., & Horstmann, R. D. (1998) · Nature Genetics · doi:10.1038/ng0398-262 · Cited by 458
Subthalamic nucleus‐mediated excitotoxicity in parkinson's disease: A target for neuroprotection
Rodriguez, M. C., Obeso, J. A., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440726 · Cited by 396
Wenning, G. K., Odin, P., Morrish, P., Rehncrona, S., Widner, H., Brundin, P., Rothwell, J. C., Brown, R., Gustavii, B., Hagell, P., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410420115 · Cited by 369
Self-citationAn [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease
Morrish, P. K., Sawle, G. V., & Brooks, D. J. (1996) · Brain · doi:10.1093/brain/119.2.585 · Cited by 366
Oxidative stress and antioxidant therapy in Parkinson's disease
Ebadi, M., Srinivasan, S. K., & Baxi, M. D. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00029-1 · Cited by 336
Mandel, R. J., Spratt, S. K., Snyder, R. O., & Leff, S. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14083 · Cited by 331
Steiner, J. P., Hamilton, G. S., Ross, D. T., Valentine, H. L., Guo, H., Connolly, M. A., Liang, S., Ramsey, C., Li, J.-H. J., Huang, W., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2019 · Cited by 327
Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
Kordower, J. H., Freeman, T. B., Chen, E., Mufson, E. J., Sanberg, P. R., Hauser, R. A., Snow, B., & Warren Olanow, C. (1998) · Movement Disorders · doi:10.1002/mds.870130303 · Cited by 298
Bilang-Bleuel, A., Revah, F., Colin, P., Locquet, I., Robert, J.-J., Mallet, J., & Horellou, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8818 · Cited by 297
Differentiation of Mesencephalic Progenitor Cells into Dopaminergic Neurons by Cytokines
Ling, Z. D., Potter, E. D., Lipton, J. W., & Carvey, P. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6715 · Cited by 295
Caspase inhibition reduces apoptosis and increases survival of nigral transplants
Schierle, G. S., Hansson, O., Leist, M., Nicotera, P., Widner, H., & Brundin, P. (1999) · Nature Medicine · doi:10.1038/4785 · Cited by 280
Levivier, M., Przedborski, S., Bencsics, C., & Kang, U. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-07810.1995 · Cited by 274
Frim, D. M., Uhler, T. A., Galpern, W. R., Beal, M. F., Breakefield, X. O., & Isacson, O. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5104 · Cited by 269
Fisher, L. J., Jinnah, H. A., Kale, L. C., Higgins, C. A., & Gage, F. H. (1991) · Neuron · doi:10.1016/0896-6273(91)90246-v · Cited by 257
Björklund, A., Rosenblad, C., Winkler, C., & Kirik, D. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0151 · Cited by 248
Self-citationFunctional neural transplantation
Dunnett, S. B., & Björklund, A. (1994) · Raven Press eBooks · Cited by 239
Self-citationAblative Surgery and Deep Brain Stimulation for Parkinson's Disease
Starr, P. A., Vitek, J. L., & Bakay, R. A. E. (1998) · Neurosurgery · doi:10.1097/00006123-199811000-00001 · Cited by 232
Zawada, W. M., Zastrow, D. J., Clarkson, E. D., Adams, F. S., Bell, K. P., & Freed, C. R. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01408-x · Cited by 220
(1996) · Neuroscience · doi:10.1016/0306-4522(96)00343-0 · Cited by 207
A fluorescent double‐labeling method to detect and confirm apoptotic nuclei in parkinson's disease
Tatton, N. A., Maclean‐Fraser, A., Tatton, W. G., Perl, D. P., & Warren, C. O. (1998) · Annals of Neurology · doi:10.1002/ana.410440721 · Cited by 202
Neural actions of immunophilin ligands
Snyder, S. H., Sabatini, D. M., Lai, M. M., Steiner, J. P., Hamilton, G. S., & Suzdak, P. D. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01146-2 · Cited by 198
Metals and free radicals in neurodegeneration
Olanow, C. W., & Arendash, G. W. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199412000-00013 · Cited by 193
Choi-Lundberg, D. L., Lin, Q., Schallert, T., Crippens, D., Davidson, B. L., Chang, Y.-N., Chiang, Y. L., Qian, J., Bardwaj, L., & Bohn, M. C. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6887 · Cited by 189
Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?
Mezey, E., Dehejia, A., Harta, G., Papp, M. I., Polymeropoulos, M. H., & Brownstein, M. J. (1998) · Nature Medicine · doi:10.1038/nm0798-755 · Cited by 184
Goetz, C. G., Stebbins, G. T., Klawans, H. L., Koller, W. C., Grossman, R. G., Bakay, R. A. E., Penn, R. D., & United Parkinson Foundation Neural Transplantation Registry (1991) · Neurology · doi:10.1212/wnl.41.11.1719 · Cited by 180
Epidemiology versus genetics in parkinson's disease: Progress in resolving an age‐old debate
Langston, J. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440707 · Cited by 165
CLINICAL RELEVANCE OF SPECIFIC IgG ANTIBODIES TO CARDIOLIPIN
Faux, J. A., Byron, M. A., & Chapel, H. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92069-2 · Cited by 165
Mortality in DATATOP: A Multicenter trial in early Parkinson's disease
Shoulson, & Parkinson Study Group (1998) · Annals of Neurology · doi:10.1002/ana.410430309 · Cited by 165
Perl, D. P., Warren, C. O., & Calne, D. B. (1998) · Annals of Neurology · doi:10.1002/ana.410440705 · Cited by 158
Tseng, J. L., Baetge, E. E., Zurn, A. D., & Aebischer, P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00325.1997 · Cited by 158
Neuroprotective and neurorestorative properties of GDNF
Gash, D. M., Zhang, Z., & Gerhardt, G. (1998) · Annals of Neurology · doi:10.1002/ana.410440718 · Cited by 158
The early diagnosis of parkinson's disease
Brooks, D. J. (1998) · Annals of Neurology · doi:10.1002/ana.410440704 · Cited by 157
Functional Recovery in Hemiparkinsonian Primates Transplanted with Polymer-Encapsulated PC12 Cells
Aebischer, P., Goddard, M. B., Signore, A. P., & Timpson, R. L. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1053 · Cited by 154
Rationale for continuous dopaminomimetic therapy of Parkinson's disease.
Chase, T. N., Baronti, F., Fabbrini, G., Heuser, I. J. E., Juncos, J. L., & Mouradian, M. M. (1989) · PubMed · Cited by 152
Lundberg, C., Horellou, P., Mallet, J. J., & Björklund, A. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0079 · Cited by 137
Self-citationGDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts
Sinclair, S. R., Svendsen, C. N., Torres, E. M., et al. (1996) · Neuroreport · doi:10.1097/00001756-199611040-00029 · Cited by 134
Neural-Targeted Gene Therapy for Rodent and Primate Hemiparkinsonism
Anton, R., Kordower, J. H., Maidment, N. T., Manaster, J. S., Kane, D. J., Rabizadeh, S., Schueler, S. B., Yang, J., Rabizadeh, S., Edwards, R. H., et al. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1097 · Cited by 134
Low frequency of α‐synuclein mutations in familial Parkinson's disease
Farrer, M. J., Vrièze, F. W., Crook, R., Boles, L., Pérez‐Tur, J., Hardy, J., Johnson, W. G., Steele, J. C., Maraganore, D. M., Gwinn, K. A., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430320 · Cited by 132
Dopamine agonists and neuroprotection in parkinson's disease
Olanow, C. W., Jenner, P. G., & Brooks, D. J. (1998) · Annals of Neurology · doi:10.1002/ana.410440725 · Cited by 131
The natural history of parkinson's disease
Poewe, W. H., & Wenning, G. K. (1998) · Annals of Neurology · doi:10.1002/ana.410440703 · Cited by 130
Fernández‐Espejo, E., Montoro, R. J., Armengol, J. A., & López‐Barneo, J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80449-3 · Cited by 129
Kordower, J. H., Styren, S., Clarke, M., DeKosky, S. T., Olanow, C. W., & Freeman, T. B. (1997) · Cell Transplantation · doi:10.1016/s0963-6897(97)00019-5 · Cited by 128
Last chance to stop and think on risks of xenotransplants
Butler, D. (1998) · Nature · doi:10.1038/34749 · Cited by 126
An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats
Winn, S. R., Wahlberg, L. U., Tresco, P. A., & Aebischer, P. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90126-x · Cited by 115
Bencsics, C. E., Wachtel, S. R., Milstien, S., Hatakeyama, K., Becker, J. B., & Kang, U. J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04449.1996 · Cited by 109
Kordower, J. H., Goetz, C. G., Freeman, T. B., & Olanow, C. W. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6386 · Cited by 108
Neural xenotransplantation: Reconstruction of neuronal circuitry across species barriers
Pakzaban, P., & Isacson, O. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90338-7 · Cited by 106
Costantini, L. C., Chaturvedi, P. R., Armistead, D. M., McCaffrey, P. G., Deacon, T. W., & Ole Isacson, A. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0185 · Cited by 105
Bouvier, M., & Mytilineou, C. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07141.1995 · Cited by 104
Programmed cell death: Does it play a role in parkinson's disease?
Burke, R. E., & Kholodilov, N. G. (1998) · Annals of Neurology · doi:10.1002/ana.410440719 · Cited by 103
Hagg, T. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6684 · Cited by 99
Bcl-xL protects adult septal cholinergic neurons from axotomized cell death
Blömer, U., Kafri, T., Randolph‐Moore, L., Verma, I. M., & Gage, F. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2603 · Cited by 89
Yurek, D. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6884 · Cited by 87
MARSDEN, C. D., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440727 · Cited by 82
Benefits and risks of hosting animal cells in the human brain
Ole Isacson, A., & Breakefield, X. O. (1997) · Nature Medicine · doi:10.1038/nm0997-964 · Cited by 65
Genetics of parkinson's disease
Gasser, T. (1998) · Annals of Neurology · doi:10.1002/ana.410440708 · Cited by 62
Leff, S. E., Rendahl, K. G., Spratt, S. K., Kang, U. J., & Mandel, R. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6803 · Cited by 59
Jordán, J., Ghadge, G. D., Prehn, J. H. M., Tóth, P. T., Roos, R. P., & Miller, R. J. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08747-4 · Cited by 57
Memory in Neurodegenerative Disease: Biological, Cognitive, and Clinical Perspectives
(1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544378 · Cited by 47
Application ofex VivoGene Therapy in the Treatment of Parkinson's Disease
Raymon, H. K., Thode, S., & Gage, F. H. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6392 · Cited by 45
Neuropathology of fetal nigral grafts in patients with Parkinson's disease.
Kordower, J. H., Freeman, T. B., & Olanow, C. W. (1998) · PubMed · Cited by 34
Neuroprotection for parkinson's disease
Koller, W. C. (1998) · Annals of Neurology · doi:10.1002/ana.410440723 · Cited by 28
Unsicker, K., Suter‐Crazzolara, C., & KRIEGLSTEIN, K. G. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514863.ch6 · Cited by 25
Kang, U. J. (1998) · PubMed · Cited by 20
The role of executive deficits in memory disorders in neurodegenerative disease
Owen, A. M., Sahakian, B. J., & Robbins, T. W. (1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544378.009 · Cited by 14
Cell death and neuroprotection in Parkinson's disease
Olanow, W. C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)82403-3 · Cited by 7
Cited by
Metabolism and functions of glutathione in brain
Dringen, R. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00060-x · Cited by 1,702
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Embryo-Derived Stem Cells: Of Mice and Men
Smith, A. G. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.435 · Cited by 1,266
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Metadata
- Authors
- Dunnett, S. B., & Björklund, A.
- Venue
- Nature
- Published
- 1999-06
- Volume
- 399
- Issue
- 6738
- Pages
- A32-A39
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2019019227
- Cited by
- 537
- References
- 88
- FWCI
- 35.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.